p12CDK2-AP1 interacts with CD82 to regulate the proliferation and survival of human oral squamous cell carcinoma

Juan Chai1, Jun Ju1, Shao-Wu Zhang2

  • 1State Key Laboratory of Military Stomatology, Department of Oral and Maxillofacial Surgery, School of Stomatology, The Fourth Military Medical University, Xi'an, Shaanxi 710032, P.R. China.

Oncology Reports
|June 29, 2016
PubMed

Insights

p12 cyclin-dependent kinase 2 (CDK2)-associating protein 1 (p12CDK2-AP1) interacts with CD82 to suppress oral cancer cell growth. Combined overexpression of both proteins shows synergistic antitumor effects in vitro and in vivo.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • p12 cyclin-dependent kinase 2 (CDK2)-associating protein 1 (p12CDK2-AP1) is known to inhibit CDK2 activity, but its precise molecular mechanism and role in cancer are not fully understood.
  • Understanding p12CDK2-AP1's interactions is crucial for elucidating its function in cellular processes relevant to cancer progression.

Purpose of the Study:

  • To identify binding proteins of p12CDK2-AP1.
  • To investigate the role of p12CDK2-AP1 in regulating the proliferation, invasion, and apoptosis of human oral squamous cell carcinoma (OSCC) cells.
  • To evaluate the combined effect of p12CDK2-AP1 and its binding partner on OSCC growth both in vitro and in vivo.

Main Methods:

  • Computational prediction of protein-protein interactions.
  • Overexpression of p12CDK2-AP1 and CD82 in OSCC-15 cells.
  • Co-immunoprecipitation (Co-IP) to confirm protein binding.
  • MTT assay for proliferation, Transwell system for invasion, and Annexin V-FITC/PI staining for apoptosis.
  • In vivo tumor xenograft models in nude mice.

Main Results:

  • Overexpression of p12CDK2-AP1 or CD82 individually suppressed OSCC cell proliferation and invasion while promoting apoptosis.
  • Combined overexpression of p12CDK2-AP1 and CD82 demonstrated synergistic antitumor activity compared to single protein overexpression.
  • Simultaneous overexpression of p12CDK2-AP1 and CD82 significantly inhibited in vivo tumor growth in nude mice.

Conclusions:

  • p12CDK2-AP1 interacts with CD82.
  • This interaction plays a significant role in suppressing the in vitro and in vivo growth of human oral squamous cell carcinoma cells.
  • The combined overexpression of p12CDK2-AP1 and CD82 exhibits potent synergistic antitumor effects, suggesting therapeutic potential.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

5.6K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K